Alendronic acid/colecalciferol

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Alendronic acid/colecalciferol
Combination of
Alendronic acidBisphosphonate
Clinical data
Trade namesFosamax Plus D, Fosavance, Adrovance, others
AHFS/Drugs.comProfessional Drug Facts
License data
  • AU: B3
Routes of
By mouth
ATC code
Legal status
Legal status

Alendronic acid/colecalciferol, sold under the brand name Fosamax Plus D among others, is a medication for the treatment of osteoporosis in men or in postmenopausal women.[2][1][3]

Alendronic acid/colecalciferol was approved for use in the United States and in the European Union in 2005.[5][4]


  1. ^ a b "Fosavance Tablets - Summary of Product Characteristics (SmPC)". (emc). Retrieved 1 March 2020.
  2. ^ a b "Fosamax Plus D- alendronate sodium and cholecalciferol tablet". DailyMed. 16 August 2019. Retrieved 1 March 2020.
  3. ^ a b "Adrovance EPAR". European Medicines Agency (EMA). 26 February 2020. Retrieved 1 March 2020.
  4. ^ a b "Fosavance EPAR". European Medicines Agency (EMA). 9 October 2019. Retrieved 1 March 2020.
  5. ^ "Drug Approval Package: Fosamax Plus D (Alendronate Sodium) NDA #021762". U.S. Food and Drug Administration (FDA). 8 June 2006. Retrieved 1 March 2020.

External links[edit]